Preoperative serum thyroglobulin concentration is an independent predictive factor of malignancy in follicular neoplasms of the thyroid gland

Journal of Surgical Oncology

Volumn 105, Issue 4, 2012, Pages 351-356

  Petric, Rok ^a   Perhavec, Andraz ^a   Gazic, Barbara ^a   Besic, Nikola ^a  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

Author keywords

follicular neoplasm; predictive factors; thyroglobulin; thyroid

Indexed keywords

THYROGLOBULIN;

ADOLESCENT; ADULT; AGED; BENIGN TUMOR; CANCER SIZE; CANCER SURGERY; CHILD; DIFFERENTIATED THYROID CANCER; FEMALE; GOITER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PREDICTIVE VALUE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SCHOOL CHILD; THYROGLOBULIN BLOOD LEVEL; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA;

ADENOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY, FINE-NEEDLE; CHILD; FEMALE; FOLLOW-UP STUDIES; GOITER; HUMANS; MALE; MIDDLE AGED; PREOPERATIVE CARE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; THYROGLOBULIN; THYROID GLAND; THYROID NEOPLASMS; THYROID NODULE; THYROIDECTOMY; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84857041022     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.22030     Document Type: Review

References (32)

1. Cooper DS, Doherty GM, Haugen BR, et al.: Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2009; 19: 1167-1214.
2. Pacini F, Schlumberger M, Dralle H, et al.: European Thyroid Cancer Taskforce. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006; 154: 787-803. (Pubitemid 43997716)
3. Baloch ZW, LiVolsi VA,: Our approach to follicular-patterned lesions of the thyroid. J Clin Pathol 2007; 60: 244-250. (Pubitemid 46447737)
4. DeMay RM,: Follicular lesions of the thyroid. Am J Clin Pathol 2000; 114: 681-683.
5. Mihai R, Parker AJ, Roskell D, Sadler GP,: One in four patients with follicular thyroid cytology (THY3) has a thyroid carcinoma. Thyroid 2009; 19: 33-37.
6. Baloch ZW, LiVolsi VA,: Fine-needle aspiration of the thyroid: Today and tomorrow. Best Pract Res Clin Endocrinol Metab 2008; 22: 929-939.
7. Rosai J,: Tumors of thyroid gland. In:, Rosai J, Carcangiu ML, Delellis RA, editors. Atlas of tumor pathology. Washington: Armed Forces Institute of Pathology; 1992. pp. 31-50.
8. Lumachi F, Borsato S, Tregnaghi A, et al.: FNA cytology and frozen section examination in patients with follicular lesions of the thyroid gland. Anticancer Res 2009; 29: 5255-5257.
9. Udelsman R, Westra WH, Donovan PI, et al.: Randomized prospective evaluation of frozen-section analysis for follicular neoplasms of the thyroid. Ann Surg 2001; 233: 716-722. (Pubitemid 32378656)
10. Yang J, Schnadig V, Logrono R, Wasserman PG,: Fine-needle aspiration of thyroid nodules: A study of 4703 patients with histologic and clinical correlations. Cancer 2007; 111: 306-315.
11. Kim ES, Nam-Goong IS, Gong G, et al.: Postoperative findings and risk for malignancy in thyroid nodules with cytological diagnosis of the so-called "follicular neoplasm ". Korean J Intern Med 2003; 18: 94-97.
12. Strazisar B, Petric R, Sesek M, et al.: Predictive factors of carcinoma in 279 patients with Hürthle cell neoplasm of the thyroid gland. J Surg Oncol 2010; 101: 582-586.
13. Besic N, Sesek M, Peric B, et al.: Predictive factors of carcinoma in 327 patients with follicular neoplasm of the thyroid. Med Sci Monit 2008; 14: CR459-CR467.
14. Luboshitzky R, Lavi I, Ishay A,: Serum thyroglobulin levels after fine-needle aspiration of thyroid nodules. Endocr Pract 2006; 12: 264-269.
15. Dralle H, Machens A,: Surgical approaches in thyroid cancer and lymph-node metastases. Best Pract Res Clin Endocrinol Metab 2008; 22: 971-987.
16. Baloch ZW, Fleisher S, LiVolsi VA, Gupta PK,: Diagnosis of "follicular neoplasm": A gray zone in thyroid fine-needle aspiration cytology. Diagn Cytopathol 2002; 26: 41-44. (Pubitemid 34037526)
17. Tyler DS, Winchester DJ, Caraway NP, et al.: Indeterminate fine-needle aspiration biopsy of the thyroid: Identification of subgroups at high risk for invasive carcinoma. Surgery 1994; 116: 1054-1060. (Pubitemid 24382166)
18. Heikkilä A, Siironen P, Hagström J, et al.: Follicular thyroid neoplasm: Clinicopathologic features suggesting malignancy. APMIS 2010; 118: 846-854.
19. Lubitz CC, Faquin WC, Yang J, et al.: Clinical and cytological features predictive of malignancy in thyroid follicular neoplasms. Thyroid 2010; 20: 25-31.
20. Raparia K, Min SK, Mody DR, et al.: Clinical outcomes for "suspicious" category in thyroid fine-needle aspiration biopsy: Patient's sex and nodule size are possible predictors of malignancy. Arch Pathol Lab Med 2009; 133: 787-790.
21. Suh I, Vriens MR, Guerrero MA, et al.: Serum thyroglobulin is a poor diagnostic biomarker of malignancy in follicular and Hurthle-cell neoplasms of the thyroid. Am J Surg 2010; 200: 41-46.
22. Paramo JC, Mesko T,: Age, tumor size, and in-office ultrasonography are predictive parameters of malignancy in follicular neoplasms of the thyroid. Endocr Pract 2008; 14: 447-451.
23. Schlinkert RT, van Heerden JA, Goellner JR, et al.: Factors that predict malignant thyroid lesions when fine-needle aspiration is "suspicious for follicular neoplasm ". Mayo Clin Proc 1997; 72: 913-916.
24. Tuttle RM, Lemar H, Burch HB,: Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration. Thyroid 1998; 8: 377-383. (Pubitemid 28252418)
25. Raber W, Kaserer K, Niederle B, Vierhapper H,: Risk factors for malignancy of thyroid nodules initially identified as follicular neoplasia by fine-needle aspiration: Results of a prospective study of one hundred twenty patients. Thyroid 2000; 10: 709-712.
26. Gulcelik NE, Gulcelik MA, Kuru B,: Risk of malignancy in patients with follicular neoplasm: Predictive value of clinical and ultrasonographic features. Arch Otolaryngol Head Neck Surg 2008; 134: 1312-1315.
27. Choi YJ, Yun JS, Kim DH,: Clinical and ultrasound features of cytology diagnosed follicular neoplasm. Endocr J 2009; 56: 383-389.
28. Rasmussen LB, Ovesen L, Bülow I, et al.: Relations between various measures of iodine intake and thyroid volume, thyroid nodularity, and serum thyroglobulin. Am J Clin Nutr 2002; 76: 1069-1076. (Pubitemid 35244679)
29. Sugino K, Ito K, Mimura T, et al.: Hürthle cell tumor of thyroid: Analysis of 188 cases. World J Surg 2001; 25: 1160-1163. (Pubitemid 32845829)
30. Hocevar M, Auersperg M,: Role of serum thyroglobulin in the preoperative evaluation of follicular thyroid tumors. Eur J Surg Oncol 1998; 24: 553-557. (Pubitemid 28566903)
31. Freitas BC, Cerutti JM,: Genetic markers differentiating follicular thyroid carcinoma from benign lesions. Mol Cell Endocrinol 2010; 321: 77-85.
32. Cerutti JM, Latini FR, Nakabashi C, et al.: Diagnosis of suspicious thyroid nodules using four protein biomarkers. Clin Cancer Res 2006; 12: 3311-3318.